Presence of 1q21 Gain and Amplification May be Associated With Poorer Outcomes in Daratumumab-treated Multiple Myeloma Patients

Clin Lymphoma Myeloma Leuk. 2025 Apr;25(4):243-248. doi: 10.1016/j.clml.2024.11.002. Epub 2024 Nov 9.
No abstract available

Publication types

  • Editorial